首页 > 最新文献

Maturitas最新文献

英文 中文
Vaginal symptoms and sexual function in climacteric women experiencing stress urinary incontinence: a secondary analysis from a six-month follow-up of a randomised trial comparing microablative radiofrequency, pelvic floor muscle training, and combination treatments 经历压力性尿失禁的更年期妇女的阴道症状和性功能:对一项比较微消融射频、盆底肌肉训练和联合治疗的随机试验进行6个月随访的二次分析
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-11 DOI: 10.1016/j.maturitas.2025.108777
Anna Lygia B. Lunardi , Cassia R.T. Juliato , Helena Slongo , Cassio L.Z. Riccetto

Objectives

To compare microablative fractional radiofrequency (FMRF), pelvic floor muscle training (PFMT), and their combination (PFMT+FMRF) on vaginal symptoms, quality of life, and sexual function in incontinent climacteric women.

Methods

Secondary outcomes from a prospective, blinded, three-arm randomised controlled trial with 117 women (39 per group), assessed at pre-treatment, one month, and six months using: International Consultation on Incontinence Questionnaire–Vaginal Symptoms (ICIQ-VS), Female Sexual Function Index (FSFI), cytology, Vaginal Health Index (VHI), and transabdominal ultrasound to measure vaginal wall thickness.

Results

All groups showed significant improvement over time in ICIQ-VS total score, laxity, dryness, impact on sex life, abdominal pain, vaginal soreness (p < 0.0001 for all questions), reduced sensation (p = 0.0004), and impairment of sex life (p = 0.0005). Only the FMRF group had sustained improvement in daily life interference at six months (p = 0.0419; CL pre vs post: −63.2 [−94.7;-31.8], pre vs 6 months: −45.7 [−79.4;-12.0]). FSFI improvements (total and domains) were not sustained at six months: total score (0.0102), desire (0.0134), lubrication (0.0093), satisfaction (0.0239), pain (0.0430). VHI showed significant, treatment-dependent differences: for moisture, FMRF improved pre- vs post-treatment (p = 0.0209; CL: 4.5 [2.4;26.6]), FMRF+PFMT improved over time (p = 0.0209; CL: 24.3 [10.6;38.0], 18.6 [4.2;32.9]); for fluid volume, FMRF+PFMT improved (p = 0.0004; CL: 27.6 [12.2;43], 24.7 [8.5;40.8]); for total score, FMRF improved pre- vs post-treatment (p = 0.0028; CL: 13.2 [4.4;22.1]), and FMRF+PFMT improved over time (p = 0.0028; CL: 21.6 [11.7;31.5], 18.9 [8.5;29.3]). All groups improved in pH (p < 0.0001) and epithelial integrity (p < 0.0001); however, the improvement in elasticity (p = 0.0001) was not sustained at six months. Vaginal wall thickness increased similarly across groups.

Conclusion

At six-month follow-up, all groups had similar improvements in quality of life, vaginal health, and sexual function.

Trial registration

This trial is registered on REBEC (Registro Brasileiro de Ensaios Clínicos; Brazilian Registry of Clinical Trials) under number RBR-9v3q33.
目的比较微消融分数射频(FMRF)、盆底肌训练(PFMT)及其联合(PFMT+FMRF)对失禁更年期女性阴道症状、生活质量和性功能的影响。方法:117名女性(每组39名)参加的前瞻性、盲法、三组随机对照试验的二级结果,在治疗前、1个月和6个月评估:国际失禁问卷咨询-阴道症状(ICIQ-VS)、女性性功能指数(FSFI)、细胞学、阴道健康指数(VHI)和经腹超声测量阴道壁厚度。结果随时间推移,所有组在ICIQ-VS总分、松弛、干燥、对性生活的影响、腹痛、阴道疼痛(所有问题p <; 0.0001)、感觉下降(p = 0.0004)和性生活损害(p = 0.0005)方面均有显著改善。只有FMRF组在6个月时日常生活干扰持续改善(p = 0.0419; CL前后对比:−63.2[−94.7;-31.8],CL前后对比:−45.7[−79.4;-12.0])。FSFI的改善(总和领域)在6个月后没有持续:总分(0.0102),欲望(0.0134),润滑(0.0093),满意度(0.0239),疼痛(0.0430)。VHI表现出显著的处理依赖性差异:对于水分,FMRF改善了处理前与处理后(p = 0.0209; CL: 4.5 [2.4;26.6]), FMRF+PFMT随时间改善(p = 0.0209; CL: 24.3 [10.6;38.0], 18.6 [4.2;32.9]);对于液体体积,FMRF+PFMT改善(p = 0.0004; CL: 27.6 [12.2;43], 24.7 [8.5;40.8]);对于总分而言,FMRF治疗前后改善(p = 0.0028; CL: 13.2 [4.4;22.1]), FMRF+PFMT随时间改善(p = 0.0028; CL: 21.6[11.7;31.5], 18.9[8.5;29.3])。各组pH值(p < 0.0001)和上皮完整性(p < 0.0001)均有改善;然而,弹性的改善(p = 0.0001)并没有持续到6个月。阴道壁厚度在各组间增加相似。结论在六个月的随访中,所有组在生活质量、阴道健康和性功能方面都有相似的改善。试验注册本试验在REBEC (Registro Brasileiro de Ensaios Clínicos;巴西临床试验注册中心)注册,编号为RBR-9v3q33。
{"title":"Vaginal symptoms and sexual function in climacteric women experiencing stress urinary incontinence: a secondary analysis from a six-month follow-up of a randomised trial comparing microablative radiofrequency, pelvic floor muscle training, and combination treatments","authors":"Anna Lygia B. Lunardi ,&nbsp;Cassia R.T. Juliato ,&nbsp;Helena Slongo ,&nbsp;Cassio L.Z. Riccetto","doi":"10.1016/j.maturitas.2025.108777","DOIUrl":"10.1016/j.maturitas.2025.108777","url":null,"abstract":"<div><h3>Objectives</h3><div>To compare microablative fractional radiofrequency (FMRF), pelvic floor muscle training (PFMT), and their combination (PFMT+FMRF) on vaginal symptoms, quality of life, and sexual function in incontinent climacteric women.</div></div><div><h3>Methods</h3><div>Secondary outcomes from a prospective, blinded, three-arm randomised controlled trial with 117 women (39 per group), assessed at pre-treatment, one month, and six months using: International Consultation on Incontinence Questionnaire–Vaginal Symptoms (ICIQ-VS), Female Sexual Function Index (FSFI), cytology, Vaginal Health Index (VHI), and transabdominal ultrasound to measure vaginal wall thickness.</div></div><div><h3>Results</h3><div>All groups showed significant improvement over time in ICIQ-VS total score, laxity, dryness, impact on sex life, abdominal pain, vaginal soreness (<em>p</em> &lt; 0.0001 for all questions), reduced sensation (<em>p</em> = 0.0004), and impairment of sex life (<em>p</em> = 0.0005). Only the FMRF group had sustained improvement in daily life interference at six months (<em>p</em> = 0.0419; CL pre vs post: −63.2 [−94.7;-31.8], pre vs 6 months: −45.7 [−79.4;-12.0]). FSFI improvements (total and domains) were not sustained at six months: total score (0.0102), desire (0.0134), lubrication (0.0093), satisfaction (0.0239), pain (0.0430). VHI showed significant, treatment-dependent differences: for moisture, FMRF improved pre- vs post-treatment (<em>p</em> = 0.0209; CL: 4.5 [2.4;26.6]), FMRF+PFMT improved over time (p = 0.0209; CL: 24.3 [10.6;38.0], 18.6 [4.2;32.9]); for fluid volume, FMRF+PFMT improved (<em>p</em> = 0.0004; CL: 27.6 [12.2;43], 24.7 [8.5;40.8]); for total score, FMRF improved pre- vs post-treatment (<em>p</em> = 0.0028; CL: 13.2 [4.4;22.1]), and FMRF+PFMT improved over time (p = 0.0028; CL: 21.6 [11.7;31.5], 18.9 [8.5;29.3]). All groups improved in pH (<em>p</em> &lt; 0.0001) and epithelial integrity (p &lt; 0.0001); however, the improvement in elasticity (<em>p</em> = 0.0001) was not sustained at six months. Vaginal wall thickness increased similarly across groups.</div></div><div><h3>Conclusion</h3><div>At six-month follow-up, all groups had similar improvements in quality of life, vaginal health, and sexual function.</div></div><div><h3>Trial registration</h3><div>This trial is registered on REBEC (Registro Brasileiro de Ensaios Clínicos; Brazilian Registry of Clinical Trials) under number RBR-9v3q33.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"204 ","pages":"Article 108777"},"PeriodicalIF":3.6,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145618320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of intra-articular hyaluronic acid injections on pain and function in patients with knee osteoarthritis: An umbrella review of systematic reviews and meta-analyses of randomized placebo-controlled trials 关节内注射透明质酸对膝关节骨关节炎患者疼痛和功能的影响:随机安慰剂对照试验的系统评价和荟萃分析综述
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-11 DOI: 10.1016/j.maturitas.2025.108779
Olivier Bruyère , Majed Alokail , Nasser Al-Daghri , Jean-Yves Reginster , Shaun Sabico
<div><h3>Introduction</h3><div>Knee osteoarthritis is a prevalent and disabling condition characterized by pain and functional impairment. Intra-articular hyaluronic acid injections are widely used for symptom relief, but their efficacy remains debated due to conflicting conclusions across systematic reviews and meta-analyses. This umbrella review assesses the symptomatic efficacy of intra-articular hyaluronic acid based on evidence reported by previously conducted systematic reviews and meta-analyses, identifies factors contributing to discrepancies in findings, and summarizes consistent outcome trends.</div></div><div><h3>Methods</h3><div>This umbrella review followed the Cochrane guidelines for overviews of reviews and adhered to the PRIOR reporting checklist. A systematic search was conducted in Medline (Ovid), the Cochrane Database of Systematic Reviews (Ovid CDSR), and Embase, using a predefined Population/Intervention/Comparator/Outcome/Study design (PICOS) framework. Systematic reviews of randomized controlled trials evaluating the efficacy of intra-articular hyaluronic acid on pain and/or function compared with placebo were included. Exclusion criteria were systematic reviews that included both randomized controlled trials and non-randomized controlled trials without separate synthesis of data from the former, scoping reviews, abstracts, commentaries, or narrative reviews. Two independent reviewers screened titles/abstracts, and full texts, resolving disagreements by consensus. Risk of bias was assessed using the AMSTAR-2 checklist, classifying systematic reviews as high, moderate, low, or critically low quality.</div></div><div><h3>Results</h3><div>Twenty-two systematic reviews were included, with AMSTAR-2 quality ratings as follows: four high, one moderate, three low, and fourteen critically low. The majority (20/22) reported statistically significant beneficial effects of intra-articular hyaluronic acid injections on pain and function. However, according to the interpretation of their authors, fifteen systematic reviews concluded positively, three provided mixed interpretations, and four concluded negatively. All five of the reviews of high or moderate quality reported statistically significant beneficial effects, but with three concluding positively and two negatively. Negative or mixed conclusions were primarily attributed to restrictive inclusion criteria (e.g., analyses only of large trials, minimum patient numbers, long follow-up periods) and challenges in interpreting clinical relevance.</div></div><div><h3>Conclusion</h3><div>Most systematic reviews and all high-quality systematic reviews support the symptomatic efficacy of intra-articular hyaluronic acid in knee osteoarthritis. Negative interpretations arise when restrictive inclusion criteria challenge the clinical relevance of results. However, given the methodological limitations, variability in review quality, and inconsistent interpretations, the overall certainty of evid
膝骨关节炎是一种常见的致残疾病,其特征是疼痛和功能损害。关节内透明质酸注射被广泛用于缓解症状,但由于系统评价和荟萃分析的结论相互矛盾,其疗效仍存在争议。本综述基于先前进行的系统综述和荟萃分析报告的证据,评估了关节内透明质酸的对症疗效,确定了导致结果差异的因素,并总结了一致的结果趋势。方法本综述遵循Cochrane综述指南,并遵循PRIOR报告清单。采用预定义的人群/干预/比较者/结果/研究设计(PICOS)框架,在Medline (Ovid)、Cochrane系统评价数据库(Ovid CDSR)和Embase中进行系统检索。本研究纳入了评价关节内透明质酸与安慰剂相比对疼痛和/或功能的疗效的随机对照试验的系统评价。排除标准是系统评价,包括随机对照试验和非随机对照试验,不包括随机对照试验、范围评价、摘要、评论或叙述性评价的单独综合数据。两位独立审稿人筛选标题/摘要和全文,通过协商一致解决分歧。使用AMSTAR-2检查表评估偏倚风险,将系统评价分为高、中、低或极低质量。结果共纳入22篇系统评价,AMSTAR-2质量等级为高4篇、中1篇、低3篇、极低14篇。大多数(20/22)报告了统计上显著的关节内透明质酸注射对疼痛和功能的有益效果。然而,根据其作者的解释,15篇系统综述得出了肯定的结论,3篇给出了混合的解释,4篇得出了否定的结论。所有5篇高质量或中等质量的综述都报告了统计学上显著的有益效果,但其中3篇结论是积极的,2篇是消极的。负面或混合结论主要归因于限制性纳入标准(例如,仅对大型试验进行分析,患者人数最少,随访时间长)以及解释临床相关性方面的挑战。结论大部分系统评价和所有高质量的系统评价均支持关节内透明质酸治疗膝关节骨性关节炎的对症疗效。当限制性纳入标准对结果的临床相关性提出质疑时,就会出现负面解释。然而,考虑到方法学的局限性、评价质量的可变性和不一致的解释,证据的总体确定性仍然有限。这些发现强调了在系统评价中需要标准化的方法,以便为临床实践提供更清晰的指导。普洛斯彼罗注册号CRD42024625696。
{"title":"Effects of intra-articular hyaluronic acid injections on pain and function in patients with knee osteoarthritis: An umbrella review of systematic reviews and meta-analyses of randomized placebo-controlled trials","authors":"Olivier Bruyère ,&nbsp;Majed Alokail ,&nbsp;Nasser Al-Daghri ,&nbsp;Jean-Yves Reginster ,&nbsp;Shaun Sabico","doi":"10.1016/j.maturitas.2025.108779","DOIUrl":"10.1016/j.maturitas.2025.108779","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Introduction&lt;/h3&gt;&lt;div&gt;Knee osteoarthritis is a prevalent and disabling condition characterized by pain and functional impairment. Intra-articular hyaluronic acid injections are widely used for symptom relief, but their efficacy remains debated due to conflicting conclusions across systematic reviews and meta-analyses. This umbrella review assesses the symptomatic efficacy of intra-articular hyaluronic acid based on evidence reported by previously conducted systematic reviews and meta-analyses, identifies factors contributing to discrepancies in findings, and summarizes consistent outcome trends.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;This umbrella review followed the Cochrane guidelines for overviews of reviews and adhered to the PRIOR reporting checklist. A systematic search was conducted in Medline (Ovid), the Cochrane Database of Systematic Reviews (Ovid CDSR), and Embase, using a predefined Population/Intervention/Comparator/Outcome/Study design (PICOS) framework. Systematic reviews of randomized controlled trials evaluating the efficacy of intra-articular hyaluronic acid on pain and/or function compared with placebo were included. Exclusion criteria were systematic reviews that included both randomized controlled trials and non-randomized controlled trials without separate synthesis of data from the former, scoping reviews, abstracts, commentaries, or narrative reviews. Two independent reviewers screened titles/abstracts, and full texts, resolving disagreements by consensus. Risk of bias was assessed using the AMSTAR-2 checklist, classifying systematic reviews as high, moderate, low, or critically low quality.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Twenty-two systematic reviews were included, with AMSTAR-2 quality ratings as follows: four high, one moderate, three low, and fourteen critically low. The majority (20/22) reported statistically significant beneficial effects of intra-articular hyaluronic acid injections on pain and function. However, according to the interpretation of their authors, fifteen systematic reviews concluded positively, three provided mixed interpretations, and four concluded negatively. All five of the reviews of high or moderate quality reported statistically significant beneficial effects, but with three concluding positively and two negatively. Negative or mixed conclusions were primarily attributed to restrictive inclusion criteria (e.g., analyses only of large trials, minimum patient numbers, long follow-up periods) and challenges in interpreting clinical relevance.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Most systematic reviews and all high-quality systematic reviews support the symptomatic efficacy of intra-articular hyaluronic acid in knee osteoarthritis. Negative interpretations arise when restrictive inclusion criteria challenge the clinical relevance of results. However, given the methodological limitations, variability in review quality, and inconsistent interpretations, the overall certainty of evid","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"203 ","pages":"Article 108779"},"PeriodicalIF":3.6,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145529120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the association between dietary metals and prostate health: Identifying benign prostatic hyperplasia using a SHAP-based interpretable machine learning model in US adults 揭示膳食金属与前列腺健康之间的关系:在美国成年人中使用基于shap的可解释机器学习模型识别良性前列腺增生。
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-11 DOI: 10.1016/j.maturitas.2025.108776
Yan Wang , Jiaming Chen , Wangqiang Chen , Xuejuan Jiang , Caifei Ding , Jingyu Zhu

Background

Benign prostatic hyperplasia affects roughly 50 % of men aged 51–60 and 70 % of those aged 61–70. While heavy metals have been linked to prostate cancer and inflammation, little is known about how the dietary intake of trace metals influences BPH risk. This study aimed to establish an interpretable, machine-learning–based framework using U.S. NHANES data to identify key dietary metals associated with BPH risk.

Methods

We analyzed adult male participants from NHANES cycles 2005–2008, extracting daily intake estimates for six trace metals. This study compared six algorithms to elucidate the relationship between dietary metal intake and BPH risk, assessing their performance in associating BPH risk across seven evaluation metrics to identify the optimal model and enhance interpretability through analysis with SHapley Additive exPlanations (SHAP). Subgroup analyses explored nonlinear intake–risk relationships.

Results

LightGBM demonstrated superior performance (AUC = 0.668). SHAP ranking identified zinc, iron, and selenium as the top protective nutrients. The most pronounced protective effect against BPH was observed within the moderate zinc and selenium intake strata. Iron demonstrated a consistent protective association, with risk reduction observed across its intake range. Copper intake demonstrated a shift from risk reduction for BPH at low to moderate levels to an increased risk at high intake levels.

Conclusions

These findings suggest that calibrated intake of these key micronutrients may attenuate BPH susceptibility, providing a data-driven foundation for targeted nutritional interventions and public-health strategies.
背景:大约50%的51-60岁男性和70%的61-70岁男性患有良性前列腺增生。虽然重金属与前列腺癌和炎症有关,但人们对微量金属的饮食摄入如何影响前列腺增生风险知之甚少。本研究旨在利用美国NHANES数据建立一个可解释的、基于机器学习的框架,以确定与BPH风险相关的关键膳食金属。方法:我们分析了2005-2008年NHANES周期的成年男性参与者,提取了六种微量金属的每日摄入量估计值。本研究比较了六种算法来阐明膳食金属摄入量与BPH风险之间的关系,通过七个评估指标评估它们在BPH风险关联方面的表现,以确定最佳模型,并通过SHapley加性解释(SHAP)分析增强可解释性。亚组分析探讨了非线性的摄入-风险关系。结果:LightGBM性能优越(AUC = 0.668)。SHAP排名将锌、铁和硒列为最重要的保护性营养素。对BPH的保护作用最显著的是在中等锌和硒摄入层。铁显示出一致的保护作用,在摄入范围内观察到风险降低。铜的摄入表明,从低至中等水平的BPH风险降低到高水平摄入时风险增加的转变。结论:这些发现表明,校准这些关键微量营养素的摄入量可能会降低BPH的易感性,为有针对性的营养干预和公共卫生策略提供数据驱动的基础。
{"title":"Unveiling the association between dietary metals and prostate health: Identifying benign prostatic hyperplasia using a SHAP-based interpretable machine learning model in US adults","authors":"Yan Wang ,&nbsp;Jiaming Chen ,&nbsp;Wangqiang Chen ,&nbsp;Xuejuan Jiang ,&nbsp;Caifei Ding ,&nbsp;Jingyu Zhu","doi":"10.1016/j.maturitas.2025.108776","DOIUrl":"10.1016/j.maturitas.2025.108776","url":null,"abstract":"<div><h3>Background</h3><div>Benign prostatic hyperplasia affects roughly 50 % of men aged 51–60 and 70 % of those aged 61–70. While heavy metals have been linked to prostate cancer and inflammation, little is known about how the dietary intake of trace metals influences BPH risk. This study aimed to establish an interpretable, machine-learning–based framework using U.S. NHANES data to identify key dietary metals associated with BPH risk.</div></div><div><h3>Methods</h3><div>We analyzed adult male participants from NHANES cycles 2005–2008, extracting daily intake estimates for six trace metals. This study compared six algorithms to elucidate the relationship between dietary metal intake and BPH risk, assessing their performance in associating BPH risk across seven evaluation metrics to identify the optimal model and enhance interpretability through analysis with SHapley Additive exPlanations (SHAP). Subgroup analyses explored nonlinear intake–risk relationships.</div></div><div><h3>Results</h3><div>LightGBM demonstrated superior performance (AUC = 0.668). SHAP ranking identified zinc, iron, and selenium as the top protective nutrients. The most pronounced protective effect against BPH was observed within the moderate zinc and selenium intake strata. Iron demonstrated a consistent protective association, with risk reduction observed across its intake range. Copper intake demonstrated a shift from risk reduction for BPH at low to moderate levels to an increased risk at high intake levels.</div></div><div><h3>Conclusions</h3><div>These findings suggest that calibrated intake of these key micronutrients may attenuate BPH susceptibility, providing a data-driven foundation for targeted nutritional interventions and public-health strategies.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"203 ","pages":"Article 108776"},"PeriodicalIF":3.6,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145552438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term subjective assessment of tension-free vaginal tape for recurrent stress urinary incontinence: A comparison with primary trans-obturator tape 无张力阴道带治疗复发性压力性尿失禁的长期主观评价:与初次经闭孔带的比较。
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-11 DOI: 10.1016/j.maturitas.2025.108778
Michael Babin , Ehud Grinstein , Masha Ben-Zvi , Irit Segman , Jonathan Harmatz , Ohad Gluck , Ron Sagiv , Shimon Ginath

Objectives

Stress urinary incontinence (SUI) affects 10–20 % of the female population. The primary surgical treatment for women with SUI is mid-urethral sling surgery (MUS). No clear guidelines exist for second-line management in patients with recurrences. This study compared quality of life and the occurrence of urinary symptoms after a secondary retropubic tension-free vaginal tape (TVT) intervention in patients with failure of primary transobturator tape (TOT) surgery with those who had experienced successful primary TOT surgery.

Methods

We conducted a retrospective cross-sectional study to compare efficacy and quality of life in patients who underwent the primary TOT procedure versus those who had a secondary TVT intervention after a failed TOT surgery. The Urinary Distress Inventory 6 (UDI-6) (questions 15–20 in the PFDI-20) was used to assess urinary symptoms.

Results

Sixty-seven patients were enrolled in the study. Forty-five patients underwent successful primary TOT surgery (defined as no bothersome SUI symptoms post-surgery), while twenty-two underwent secondary TVT surgery for recurrent symptoms. Basic demographic characteristics were comparable in both groups. The median follow-up was 32 months for the successful primary TOT group and 25.5 months for the secondary TVT group (p = 0.33). There were no significant differences in UDI-6 scores (24.3 ± 25.3 for the successful primary TOT group versus 29.5 ± 27.2 for the secondary TVT group, p = 0.44). Rates of stress urinary incontinence, urgency urinary incontinence, and voiding dysfunction were also comparable between the groups. There were no surgical complications in the secondary TVT group.

Conclusion

Quality of life, as assessed by the UDI-6 inventory, and rates of urinary symptoms were similar in the secondary TVT and successful primary TOT groups. The secondary TVT procedure may present a favorable surgical option for treating recurrent SUI after failed primary TOT.
目的:压力性尿失禁(SUI)影响10- 20%的女性人群。女性SUI的主要手术治疗是中尿道悬吊手术(MUS)。对于复发患者的二线治疗尚无明确的指南。本研究比较了首次经翻带(TOT)手术失败的患者与成功进行首次无张力阴道带(TVT)干预的患者的生活质量和泌尿系统症状的发生。方法:我们进行了一项回顾性横断面研究,比较首次接受TVT手术的患者与在失败的TVT手术后进行二次TVT干预的患者的疗效和生活质量。泌尿窘迫量表(UDI-6) (PFDI-20中的问题15-20)用于评估泌尿症状。结果:67例患者入组研究。45例患者成功进行了原发性TVT手术(定义为术后无烦人的SUI症状),而22例患者因复发症状进行了继发性TVT手术。两组的基本人口统计学特征具有可比性。初次TVT成功组的中位随访时间为32个月,二次TVT成功组的中位随访时间为25.5个月(p = 0.33)。UDI-6评分差异无统计学意义(首次TVT组为24.3±25.3,二次TVT组为29.5±27.2,p = 0.44)。应激性尿失禁、急迫性尿失禁和排尿功能障碍的发生率在两组之间也具有可比性。继发性TVT组无手术并发症。结论:UDI-6量表评估的生活质量和泌尿系统症状发生率在继发性TVT组和成功的原发性TOT组相似。继发性TVT手术可能是治疗原发性TVT失败后复发性SUI的良好手术选择。
{"title":"Long-term subjective assessment of tension-free vaginal tape for recurrent stress urinary incontinence: A comparison with primary trans-obturator tape","authors":"Michael Babin ,&nbsp;Ehud Grinstein ,&nbsp;Masha Ben-Zvi ,&nbsp;Irit Segman ,&nbsp;Jonathan Harmatz ,&nbsp;Ohad Gluck ,&nbsp;Ron Sagiv ,&nbsp;Shimon Ginath","doi":"10.1016/j.maturitas.2025.108778","DOIUrl":"10.1016/j.maturitas.2025.108778","url":null,"abstract":"<div><h3>Objectives</h3><div>Stress urinary incontinence (SUI) affects 10–20 % of the female population. The primary surgical treatment for women with SUI is mid-urethral sling surgery (MUS). No clear guidelines exist for second-line management in patients with recurrences. This study compared quality of life and the occurrence of urinary symptoms after a secondary retropubic tension-free vaginal tape (TVT) intervention in patients with failure of primary transobturator tape (TOT) surgery with those who had experienced successful primary TOT surgery.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cross-sectional study to compare efficacy and quality of life in patients who underwent the primary TOT procedure versus those who had a secondary TVT intervention after a failed TOT surgery. The Urinary Distress Inventory 6 (UDI-6) (questions 15–20 in the PFDI-20) was used to assess urinary symptoms.</div></div><div><h3>Results</h3><div>Sixty-seven patients were enrolled in the study. Forty-five patients underwent successful primary TOT surgery (defined as no bothersome SUI symptoms post-surgery), while twenty-two underwent secondary TVT surgery for recurrent symptoms. Basic demographic characteristics were comparable in both groups. The median follow-up was 32 months for the successful primary TOT group and 25.5 months for the secondary TVT group (<em>p</em> = 0.33). There were no significant differences in UDI-6 scores (24.3 ± 25.3 for the successful primary TOT group versus 29.5 ± 27.2 for the secondary TVT group, <em>p</em> = 0.44). Rates of stress urinary incontinence, urgency urinary incontinence, and voiding dysfunction were also comparable between the groups. There were no surgical complications in the secondary TVT group.</div></div><div><h3>Conclusion</h3><div>Quality of life, as assessed by the UDI-6 inventory, and rates of urinary symptoms were similar in the secondary TVT and successful primary TOT groups. The secondary TVT procedure may present a favorable surgical option for treating recurrent SUI after failed primary TOT.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"203 ","pages":"Article 108778"},"PeriodicalIF":3.6,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145524920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A mixed-methods investigation of women's health-friendly organisations as perceived by menopausal working women 对绝经期工作妇女认为的妇女健康友好组织的混合方法调查。
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-06 DOI: 10.1016/j.maturitas.2025.108775
Claire Hardy , Amanda Griffiths , Eleanor Thorne , Myra S. Hunter

Objectives

To examine women's perspectives on what constitutes a women's health-friendly work culture, and to assess whether perceiving one's organisation as women's health-friendly is associated with menopausal symptom experience and work-related outcomes.

Methods

A cross-sectional mixed-methods online survey collected self-reported quantitative and qualitative data from working menopausal women. Primary outcome measures included presence of menopausal symptoms (past four weeks), vasomotor symptom problem rating, job stress, and whether participants perceived their organisation as supportive of women's health (dependent variable). Two open-ended questions explored participants' views on what makes a work culture friendly or unfriendly to women's health.

Results

From the responses of 300 participants, over two-thirds (65.7%) perceived their organisation as supportive of women's health. These participants reported significantly lower job stress and less problematic vasomotor symptoms than those who did not. No significant association was found between menopausal symptom presence. Thematic analysis of qualitative responses revealed two overarching themes capturing shared perceptions of women's health-friendly and unfriendly work cultures. Theme 1 focused on the people at work: awareness and understanding of women's health, attitudes towards women and work, and their talking about women's health at work. Theme 2 addressed more structural factors of organisational arrangements and provisions: flexibility in work arrangements, resources and support, and the physical work environment.

Conclusions

This study provides novel insights into how women perceive a health-friendly work culture and the potential relevance to menopausal experiences and work. The findings have clear implications for policy and practice, warranting further attention and investigation.
目的:研究妇女对什么是妇女健康友好型工作文化的看法,并评估认为一个组织对妇女健康友好型是否与更年期症状经历和与工作有关的结果有关。方法:采用横断面混合方法在线调查,收集绝经期工作妇女自我报告的定量和定性数据。主要结果测量包括绝经期症状(过去四周)、血管舒缩症状问题评分、工作压力以及参与者是否认为他们的组织支持女性健康(因变量)。两个开放式问题探讨了参与者对什么使工作文化对女性健康友好或不友好的看法。结果:在300名参与者的答复中,超过三分之二(65.7%)的人认为他们的组织支持妇女的健康。这些参与者报告的工作压力和有问题的血管舒缩症状明显低于那些没有报告的人。绝经期症状之间没有明显的联系。对定性答复的专题分析揭示了两个总体主题,反映了对妇女健康友好型和不友好型工作文化的共同看法。主题1的重点是工作中的人:对妇女健康的认识和理解、对妇女和工作的态度以及她们对工作中的妇女健康的讨论。主题2涉及组织安排和规定的更多结构性因素:工作安排的灵活性、资源和支助以及实际工作环境。结论:这项研究为女性如何看待健康友好的工作文化以及绝经期经历和工作的潜在相关性提供了新的见解。研究结果对政策和实践具有明确的影响,值得进一步关注和调查。
{"title":"A mixed-methods investigation of women's health-friendly organisations as perceived by menopausal working women","authors":"Claire Hardy ,&nbsp;Amanda Griffiths ,&nbsp;Eleanor Thorne ,&nbsp;Myra S. Hunter","doi":"10.1016/j.maturitas.2025.108775","DOIUrl":"10.1016/j.maturitas.2025.108775","url":null,"abstract":"<div><h3>Objectives</h3><div>To examine women's perspectives on what constitutes a women's health-friendly work culture, and to assess whether perceiving one's organisation as women's health-friendly is associated with menopausal symptom experience and work-related outcomes.</div></div><div><h3>Methods</h3><div>A cross-sectional mixed-methods online survey collected self-reported quantitative and qualitative data from working menopausal women. Primary outcome measures included presence of menopausal symptoms (past four weeks), vasomotor symptom problem rating, job stress, and whether participants perceived their organisation as supportive of women's health (dependent variable). Two open-ended questions explored participants' views on what makes a work culture friendly or unfriendly to women's health.</div></div><div><h3>Results</h3><div>From the responses of 300 participants, over two-thirds (65.7%) perceived their organisation as supportive of women's health. These participants reported significantly lower job stress and less problematic vasomotor symptoms than those who did not. No significant association was found between menopausal symptom presence. Thematic analysis of qualitative responses revealed two overarching themes capturing shared perceptions of women's health-friendly and unfriendly work cultures. Theme 1 focused on the <em>people at work</em>: <em>awareness and understanding</em> of women's health, <em>attitudes towards women and work</em>, and their <em>talking about women's health at work</em>. Theme 2 addressed more structural factors of <em>organisational arrangements and provisions</em>: <em>flexibility in work arrangements</em>, <em>resources and support</em>, and the <em>physical work environment</em>.</div></div><div><h3>Conclusions</h3><div>This study provides novel insights into how women perceive a health-friendly work culture and the potential relevance to menopausal experiences and work. The findings have clear implications for policy and practice, warranting further attention and investigation.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"205 ","pages":"Article 108775"},"PeriodicalIF":3.6,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145696460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual wellbeing in vulvodynia: A narrative review 外阴痛的性健康:叙述回顾
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-02 DOI: 10.1016/j.maturitas.2025.108773
Caroline F. Pukall , Melody Garas , Natalie O. Rosen , Sophie Bergeron , Michele Chittenden
Vulvodynia, defined as idiopathic chronic vulvar pain, is a prevalent and distressing condition that entails significant impacts on many aspects of psychosocial wellbeing. Given the location of the pain in vulvodynia and the unique sexual challenges faced by individuals with this condition, the purpose of the present paper was to narratively review the literature on sexual wellbeing in vulvodynia. In the face of evolving definitions of sexual wellbeing, we examined the following aspects: sexual function, pain during sexual activity, sexual satisfaction, sexual pleasure, and genital self-image. Secondary aims were to examine the frequency with which these aspects are studied, to report on premenopausal or postmenopausal status of the samples, and to describe the subtypes of vulvodynia featured in the literature. A search for articles in Medline, PsycINFO, and Web of Science examining these aspects in the last 10 years yielded 54 studies for inclusion and extraction. Results indicated that sexual function, pain during sexual activity, and sexual satisfaction are the most common aspects of sexual wellbeing studied in the vulvodynia literature. Sexual pleasure and genital self-image, however, are not frequently assessed in vulvodynia studies. In addition, the vulvodynia literature focused predominantly on premenopausal samples with provoked pain. Numerous psychosocial factors were found to be associated with sexual wellbeing outcomes, including intrapersonal and interpersonal aspects. These factors should be considered as intervention targets in the management of vulvodynia, given the widespread effects of this condition.
外阴痛被定义为特发性慢性外阴疼痛,是一种普遍和令人痛苦的疾病,对心理社会健康的许多方面产生重大影响。鉴于外阴痛疼痛的位置和独特的性挑战所面临的个人与这种情况下,本论文的目的是叙述性回顾外阴痛的性福利的文献。面对不断变化的性幸福定义,我们研究了以下几个方面:性功能、性活动中的疼痛、性满足、性愉悦和生殖器自我形象。次要目的是检查这些方面的研究频率,报告绝经前或绝经后的样本状态,并描述文献中外阴痛的亚型。在Medline、PsycINFO和Web of Science上搜索过去10年里关于这些方面的文章,得出了54项研究。结果表明,性功能、性活动中的疼痛和性满意度是外阴痛文献中研究的性健康最常见的方面。然而,在外阴痛的研究中,性快感和生殖器自我形象并不经常被评估。此外,外阴痛的文献主要集中在绝经前的样本与诱发性疼痛。许多社会心理因素被发现与性健康结果有关,包括个人和人际方面。鉴于外阴痛的广泛影响,这些因素应被视为外阴痛治疗的干预目标。
{"title":"Sexual wellbeing in vulvodynia: A narrative review","authors":"Caroline F. Pukall ,&nbsp;Melody Garas ,&nbsp;Natalie O. Rosen ,&nbsp;Sophie Bergeron ,&nbsp;Michele Chittenden","doi":"10.1016/j.maturitas.2025.108773","DOIUrl":"10.1016/j.maturitas.2025.108773","url":null,"abstract":"<div><div>Vulvodynia, defined as idiopathic chronic vulvar pain, is a prevalent and distressing condition that entails significant impacts on many aspects of psychosocial wellbeing. Given the location of the pain in vulvodynia and the unique sexual challenges faced by individuals with this condition, the purpose of the present paper was to narratively review the literature on sexual wellbeing in vulvodynia. In the face of evolving definitions of sexual wellbeing, we examined the following aspects: sexual function, pain during sexual activity, sexual satisfaction, sexual pleasure, and genital self-image. Secondary aims were to examine the frequency with which these aspects are studied, to report on premenopausal or postmenopausal status of the samples, and to describe the subtypes of vulvodynia featured in the literature. A search for articles in Medline, PsycINFO, and Web of Science examining these aspects in the last 10 years yielded 54 studies for inclusion and extraction. Results indicated that sexual function, pain during sexual activity, and sexual satisfaction are the most common aspects of sexual wellbeing studied in the vulvodynia literature. Sexual pleasure and genital self-image, however, are not frequently assessed in vulvodynia studies. In addition, the vulvodynia literature focused predominantly on premenopausal samples with provoked pain. Numerous psychosocial factors were found to be associated with sexual wellbeing outcomes, including intrapersonal and interpersonal aspects. These factors should be considered as intervention targets in the management of vulvodynia, given the widespread effects of this condition.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"203 ","pages":"Article 108773"},"PeriodicalIF":3.6,"publicationDate":"2025-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145467671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitruvian Health: the future of medicine and healthcare? 维特鲁威健康:医学和医疗保健的未来?
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.maturitas.2025.108624
Oscar H. Franco
{"title":"Vitruvian Health: the future of medicine and healthcare?","authors":"Oscar H. Franco","doi":"10.1016/j.maturitas.2025.108624","DOIUrl":"10.1016/j.maturitas.2025.108624","url":null,"abstract":"","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"202 ","pages":"Article 108624"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144236341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The burden of sleep disturbances and vasomotor symptoms on work productivity, activity impairment and healthcare resource use in perimenopausal and postmenopausal women 围绝经期和绝经后妇女睡眠障碍和血管舒缩症状对工作效率、活动障碍和医疗资源使用的影响
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-11-01 DOI: 10.1016/j.maturitas.2025.108758
Paula Briggs , Carina Dinkel-Keuthage , Joehl Nguyen , Nils Schoof , Carsten Moeller , Kristina Rosa Bolling , Kushal Modi , Sheila Drakeley , Lin Yang , Shaloo Gupta , Claudio N. Soares

Objective

To explore relationships between sleep disturbances and vasomotor symptoms (VMS) with work productivity/activity impairment (WPAI) and healthcare visits among peri- and postmenopausal women.

Study design

We analyzed data from peri- and postmenopausal women aged 40–65 years who participated in the National Health and Wellness 2019/2021 survey (in the US; N = 27,621) and 2017/2020 survey (in France, Germany, Italy, Spain, and the UK; N = 20,220). We used generalized linear regression to calculate adjusted estimated marginal means (EMMs) to assess differences between four subgroups based on self-reported sleep disturbances and VMS.

Main outcome measures

Scores on the WPAI questionnaire (higher scores indicating worse outcomes); number of healthcare visits in the previous 6 months.

Results

Among postmenopausal women, those with symptoms had worse WPAI outcomes than those with neither type of symptom. The highest scores (worst outcomes) were seen for women with both symptoms: the EMMs for this group in the US survey, vs. those with neither symptom, were 11.9 % vs. 9.3 % for presenteeism, 12.8 % vs. 10.2 % for work productivity impairment, and 20.3 % vs. 16.2 % for activity impairment. Corresponding estimates for Europe were 17.4 % vs. 12.9 % for presenteeism, 18.8 % vs. 14.4 % for work productivity impairment, and 28.1 % vs. 20.9 % for activity impairment. Worse WPAI outcomes were not clearly observed in perimenopausal women with symptoms vs. those with no symptoms. However, both peri- and postmenopausal women with symptoms had more previous healthcare visits than those with neither symptom, especially those with sleep disturbances irrespective of co-occurring VMS.

Conclusions

Sleep disturbances and VMS were associated with worse WPAI scores and more healthcare visits in postmenopausal women, indicating a need for effective management of these symptoms among this population.
目的探讨围绝经期和绝经后妇女睡眠障碍、血管舒缩症状(VMS)与工作效率/活动障碍(WPAI)和保健就诊的关系。研究设计我们分析了参加2019/2021年国家健康与健康调查(美国,N = 27621)和2017/2020年调查(法国,德国,意大利,西班牙和英国,N = 20220)的40-65岁绝经前后妇女的数据。我们使用广义线性回归来计算调整后的估计边际均值(emm),以评估基于自我报告的睡眠障碍和VMS的四个亚组之间的差异。主要结果测量:WPAI问卷得分(得分越高表明结果越差);过去6个月的就医次数。结果在绝经后妇女中,有症状者的WPAI结果比无症状者更差。两种症状的女性得分最高(结果最差):在美国的调查中,这一组的emm与没有症状的女性相比,出勤率为11.9%对9.3%,工作效率障碍为12.8%对10.2%,活动障碍为20.3%对16.2%。在欧洲,出勤率分别为17.4%和12.9%,工作效率受损率分别为18.8%和14.4%,活动受损率分别为28.1%和20.9%。有症状的围绝经期妇女与无症状的围绝经期妇女的WPAI结果不明显。然而,有症状的围绝经期和绝经后妇女比没有症状的妇女有更多的医疗保健就诊,特别是那些有睡眠障碍的妇女,无论是否同时发生VMS。结论:睡眠障碍和VMS与绝经后妇女较差的WPAI评分和更多的医疗保健就诊相关,表明需要对这些症状进行有效的管理。
{"title":"The burden of sleep disturbances and vasomotor symptoms on work productivity, activity impairment and healthcare resource use in perimenopausal and postmenopausal women","authors":"Paula Briggs ,&nbsp;Carina Dinkel-Keuthage ,&nbsp;Joehl Nguyen ,&nbsp;Nils Schoof ,&nbsp;Carsten Moeller ,&nbsp;Kristina Rosa Bolling ,&nbsp;Kushal Modi ,&nbsp;Sheila Drakeley ,&nbsp;Lin Yang ,&nbsp;Shaloo Gupta ,&nbsp;Claudio N. Soares","doi":"10.1016/j.maturitas.2025.108758","DOIUrl":"10.1016/j.maturitas.2025.108758","url":null,"abstract":"<div><h3>Objective</h3><div>To explore relationships between sleep disturbances and vasomotor symptoms (VMS) with work productivity/activity impairment (WPAI) and healthcare visits among peri- and postmenopausal women.</div></div><div><h3>Study design</h3><div>We analyzed data from peri- and postmenopausal women aged 40–65 years who participated in the National Health and Wellness 2019/2021 survey (in the US; <em>N</em> = 27,621) and 2017/2020 survey (in France, Germany, Italy, Spain, and the UK; <em>N</em> = 20,220). We used generalized linear regression to calculate adjusted estimated marginal means (EMMs) to assess differences between four subgroups based on self-reported sleep disturbances and VMS.</div></div><div><h3>Main outcome measures</h3><div>Scores on the WPAI questionnaire (higher scores indicating worse outcomes); number of healthcare visits in the previous 6 months.</div></div><div><h3>Results</h3><div>Among postmenopausal women, those with symptoms had worse WPAI outcomes than those with neither type of symptom. The highest scores (worst outcomes) were seen for women with both symptoms: the EMMs for this group in the US survey, vs. those with neither symptom, were 11.9 % vs. 9.3 % for presenteeism, 12.8 % vs. 10.2 % for work productivity impairment, and 20.3 % vs. 16.2 % for activity impairment. Corresponding estimates for Europe were 17.4 % vs. 12.9 % for presenteeism, 18.8 % vs. 14.4 % for work productivity impairment, and 28.1 % vs. 20.9 % for activity impairment. Worse WPAI outcomes were not clearly observed in perimenopausal women with symptoms vs. those with no symptoms. However, both peri- and postmenopausal women with symptoms had more previous healthcare visits than those with neither symptom, especially those with sleep disturbances irrespective of co-occurring VMS.</div></div><div><h3>Conclusions</h3><div>Sleep disturbances and VMS were associated with worse WPAI scores and more healthcare visits in postmenopausal women, indicating a need for effective management of these symptoms among this population.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"203 ","pages":"Article 108758"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145474951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise intensity influences body composition: a 6-month comparison of high-intensity interval, moderate- and low-intensity training among healthy older adults 运动强度影响身体组成:健康老年人6个月的高强度间歇、中等和低强度训练比较
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-10-30 DOI: 10.1016/j.maturitas.2025.108763
Grace Rose , Emily Hume , Daniel Blackmore , Jules Mitchell , Samuel Belford , Tina Skinner , Maryam Ziaei , Stephan Riek , Perry Bartlett , Mia Schaumberg

Objective

To determine whether exercise of higher intensity can elicit greater improvements in body composition among older adults, given that body composition is implicated in the progression of chronic disease.

Study design

Sub-study of a randomised controlled trial (ACTRN12618000700235).

Main outcome measures

Healthy older adults (n = 123, average age 72.0 years, body mass index 25.8 kg/m2) completed three 45-min supervised exercise sessions per week for 6 months. Participants were randomised to treadmill-based moderate-intensity training (n = 45), or high-intensity interval training (n = 41) or a low-intensity active control condition (n = 37), with individualised heart-rate prescription. Dual-energy x-ray absorptiometry was used to quantify body composition at baseline, and at 3 and 6 months.

Results

For fat mass, both high- (p = 0.001) and moderate-intensity groups (p = 0.016) demonstrated similar reductions that were both larger than control, post-intervention. Only moderate-intensity training was associated with reductions in fat-free mass (FFM) at 0–3 (p = 0.005) and 0–6 months (p = 0.050), potentially exacerbating age-related reductions in muscle and other lean tissues. Overall, high-intensity training had greater between-group raw difference in lean mass than moderate-intensity training at 6 months (p = 0.042) and this group was the only one with a net improvement in body fat percentage (p = 0.017). Moderate-intensity (p = 0.009) and high-intensity training (p = 0.023) demonstrated comparable improvements in visceral adipose tissue over 0–6 months.

Conclusions

High-intensity training reduced fat and maintained lean mass in apparently healthy older adults, though changes were small and not clinically meaningful compared with exercise of lower intensity and considering measurement error. Where appropriate and feasible, higher-intensity exercise training may be considered to support improvements in health-related body composition in older adults.
Protocol registration: ACTRN12618000700235.
目的考虑到身体成分与慢性疾病的进展有关,确定高强度的运动是否能使老年人的身体成分得到更大的改善。研究设计随机对照试验(ACTRN12618000700235)的子研究。主要结果测量:健康老年人(123名,平均年龄72.0岁,体重指数25.8 kg/m2)每周完成3次45分钟的有监督的锻炼,持续6个月。参与者被随机分配到基于跑步机的中等强度训练(n = 45),或高强度间歇训练(n = 41)或低强度主动控制条件(n = 37),并根据个人心率处方进行训练。在基线、3个月和6个月时,采用双能x线吸收仪量化身体成分。结果干预后,高强度组(p = 0.001)和中等强度组(p = 0.016)的脂肪量减少幅度均大于对照组。在0-3个月(p = 0.005)和0-6个月(p = 0.050)时,只有中等强度的训练与无脂质量(FFM)的减少有关,这可能会加剧与年龄相关的肌肉和其他瘦组织的减少。总体而言,在6个月时,高强度训练比中等强度训练在瘦质量方面有更大的组间原始差异(p = 0.042),并且这一组是唯一一个体脂率净改善的组(p = 0.017)。中等强度训练(p = 0.009)和高强度训练(p = 0.023)在0-6个月内对内脏脂肪组织的改善具有可比性。结论高强度训练可以减少明显健康的老年人的脂肪并保持瘦质量,但与低强度运动相比,考虑到测量误差,变化很小,没有临床意义。在适当和可行的情况下,可以考虑进行高强度的运动训练,以支持改善老年人与健康有关的身体组成。协议注册:ACTRN12618000700235。
{"title":"Exercise intensity influences body composition: a 6-month comparison of high-intensity interval, moderate- and low-intensity training among healthy older adults","authors":"Grace Rose ,&nbsp;Emily Hume ,&nbsp;Daniel Blackmore ,&nbsp;Jules Mitchell ,&nbsp;Samuel Belford ,&nbsp;Tina Skinner ,&nbsp;Maryam Ziaei ,&nbsp;Stephan Riek ,&nbsp;Perry Bartlett ,&nbsp;Mia Schaumberg","doi":"10.1016/j.maturitas.2025.108763","DOIUrl":"10.1016/j.maturitas.2025.108763","url":null,"abstract":"<div><h3>Objective</h3><div>To determine whether exercise of higher intensity can elicit greater improvements in body composition among older adults, given that body composition is implicated in the progression of chronic disease.</div></div><div><h3>Study design</h3><div>Sub-study of a randomised controlled trial (ACTRN12618000700235).</div></div><div><h3>Main outcome measures</h3><div>Healthy older adults (<em>n</em> = 123, average age 72.0 years, body mass index 25.8 kg/m<sup>2</sup>) completed three 45-min supervised exercise sessions per week for 6 months. Participants were randomised to treadmill-based moderate-intensity training (<em>n</em> = 45), or high-intensity interval training (<em>n</em> = 41) or a low-intensity active control condition (<em>n</em> = 37), with individualised heart-rate prescription. Dual-energy x-ray absorptiometry was used to quantify body composition at baseline, and at 3 and 6 months.</div></div><div><h3>Results</h3><div>For fat mass, both high- (<em>p</em> = 0.001) and moderate-intensity groups (<em>p</em> = 0.016) demonstrated similar reductions that were both larger than control, post-intervention. Only moderate-intensity training was associated with reductions in fat-free mass (FFM) at 0–3 (<em>p</em> = 0.005) and 0–6 months (<em>p</em> = 0.050), potentially exacerbating age-related reductions in muscle and other lean tissues. Overall, high-intensity training had greater between-group raw difference in lean mass than moderate-intensity training at 6 months (<em>p</em> = 0.042) and this group was the only one with a net improvement in body fat percentage (<em>p</em> = 0.017). Moderate-intensity (<em>p</em> = 0.009) and high-intensity training (<em>p</em> = 0.023) demonstrated comparable improvements in visceral adipose tissue over 0–6 months.</div></div><div><h3>Conclusions</h3><div>High-intensity training reduced fat and maintained lean mass in apparently healthy older adults, though changes were small and not clinically meaningful compared with exercise of lower intensity and considering measurement error. Where appropriate and feasible, higher-intensity exercise training may be considered to support improvements in health-related body composition in older adults.</div><div>Protocol registration: ACTRN12618000700235.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"203 ","pages":"Article 108763"},"PeriodicalIF":3.6,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145419301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of menopausal hormone therapy and physical activity on sexual function among postmenopausal women 绝经期激素治疗和体力活动对绝经后妇女性功能的影响。
IF 3.6 2区 医学 Q2 GERIATRICS & GERONTOLOGY Pub Date : 2025-10-30 DOI: 10.1016/j.maturitas.2025.108772
Penghui Feng , Lin Lin , Zhuolin Xie , Xiu Lin , Jingbo Huang , Shouqing Lin , Min Luo , Qi Yu , Rong Chen

Objectives

This study investigated the association between sexual function and both menopausal hormone therapy and physical activity among postmenopausal women.

Methods

In this cross-sectional study, postmenopausal women who had used menopausal hormone therapy for at least three years were recruited as the intervention group, and those who had never used menopausal hormone therapy served as controls. Additionally, women were further categorized based on physical activity levels. All women were requested to complete the Female Sexual Function Index and the International Physical Activity Short Questionnaire for the Elderly surveys to evaluate their sexual function and physical activity levels.

Results

Application of the inclusion and exclusion criteria led to a sample size of 260 for the two study groups combined, 109 in the intervention group (who had used menopausal hormone therapy) and 151 in the control group (who had never used it). Our study revealed that menopausal hormone therapy was effective in alleviating sexual discomfort, with higher scores on the Female Sexual Function Index in the menopausal hormone therapy group compared with the control group (43.73 vs. 37.46, P < 0.05). Specifically, users of menopausal hormone therapy experienced notable improvements in lubrication, orgasm, and overall satisfaction. Intriguingly, increased physical activity was associated with reduced sexual discomfort. Improved lubrication and pain relief were observed in the moderate- and high-exercise group receiving hormone therapy compared with controls.

Conclusions

Both menopausal hormone therapy and physical exercise were related to less sexual discomfort among women in this demographic. Additionally, menopausal hormone therapy appears to enhance the benefits of exercise in addressing sexual discomfort.
目的:本研究探讨绝经后妇女的性功能与更年期激素治疗和体力活动之间的关系。方法:在这项横断面研究中,招募使用绝经期激素治疗至少三年的绝经后妇女作为干预组,而从未使用绝经期激素治疗的妇女作为对照组。此外,根据身体活动水平对女性进行了进一步分类。所有女性均完成了《女性性功能指数》和《老年人国际体育活动短问卷》调查,以评估她们的性功能和体育活动水平。结果:纳入和排除标准的应用导致两个研究组的总样本量为260例,干预组(使用绝经期激素治疗)109例,对照组(从未使用激素治疗)151例。我们的研究表明,绝经期激素治疗可以有效缓解性不适,与对照组相比,绝经期激素治疗组的女性性功能指数得分更高(43.73比37.46,P)。结论:绝经期激素治疗和体育锻炼与这一人口统计学中女性的性不适减少有关。此外,更年期激素疗法似乎增强了运动在解决性不适方面的益处。
{"title":"Impact of menopausal hormone therapy and physical activity on sexual function among postmenopausal women","authors":"Penghui Feng ,&nbsp;Lin Lin ,&nbsp;Zhuolin Xie ,&nbsp;Xiu Lin ,&nbsp;Jingbo Huang ,&nbsp;Shouqing Lin ,&nbsp;Min Luo ,&nbsp;Qi Yu ,&nbsp;Rong Chen","doi":"10.1016/j.maturitas.2025.108772","DOIUrl":"10.1016/j.maturitas.2025.108772","url":null,"abstract":"<div><h3>Objectives</h3><div>This study investigated the association between sexual function and both menopausal hormone therapy and physical activity among postmenopausal women.</div></div><div><h3>Methods</h3><div>In this cross-sectional study, postmenopausal women who had used menopausal hormone therapy for at least three years were recruited as the intervention group, and those who had never used menopausal hormone therapy served as controls. Additionally, women were further categorized based on physical activity levels. All women were requested to complete the Female Sexual Function Index and the International Physical Activity Short Questionnaire for the Elderly surveys to evaluate their sexual function and physical activity levels.</div></div><div><h3>Results</h3><div>Application of the inclusion and exclusion criteria led to a sample size of 260 for the two study groups combined, 109 in the intervention group (who had used menopausal hormone therapy) and 151 in the control group (who had never used it). Our study revealed that menopausal hormone therapy was effective in alleviating sexual discomfort, with higher scores on the Female Sexual Function Index in the menopausal hormone therapy group compared with the control group (43.73 vs. 37.46, <em>P</em> &lt; 0.05). Specifically, users of menopausal hormone therapy experienced notable improvements in lubrication, orgasm, and overall satisfaction. Intriguingly, increased physical activity was associated with reduced sexual discomfort. Improved lubrication and pain relief were observed in the moderate- and high-exercise group receiving hormone therapy compared with controls.</div></div><div><h3>Conclusions</h3><div>Both menopausal hormone therapy and physical exercise were related to less sexual discomfort among women in this demographic. Additionally, menopausal hormone therapy appears to enhance the benefits of exercise in addressing sexual discomfort.</div></div>","PeriodicalId":51120,"journal":{"name":"Maturitas","volume":"203 ","pages":"Article 108772"},"PeriodicalIF":3.6,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145552472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Maturitas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1